Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4037)
- Volume 19, 2023 (180)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 6, 2010
- Issue 1 (84)
- Supplement 1 (6)
Hyperbaric oxygen ameliorates worsening signs and symptoms of post-traumatic stress disorder
Benjamin Eovaldi, Claude Zanetti
Neuropsychiatric Disease and Treatment 2010, 6:785-789
Published Date: 6 December 2010
Functional imaging of hippocampal dysfunction among persons with Alzheimer’s disease: a proof-of-concept study
David B Arciniegas, Jason R Tregellas, Donald C Rojas, et al
Neuropsychiatric Disease and Treatment 2010, 6:779-783
Published Date: 23 November 2010
Neurocognitive impairment after off-pump and on-pump coronary artery bypass graft surgery – an Iranian experience
Mehdi Farhoudi, Kaveh Mehrvar, Abbas Afrasiabi, et al
Neuropsychiatric Disease and Treatment 2010, 6:775-778
Published Date: 19 November 2010
Walking impairment in patients with multiple sclerosis: exercise training as a treatment option
Robert W Motl, Myla D Goldman, Ralph HB Benedict
Neuropsychiatric Disease and Treatment 2010, 6:767-774
Published Date: 16 November 2010
Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
Ann E Maloney, Linmarie Sikich
Neuropsychiatric Disease and Treatment 2010, 6:749-766
Published Date: 10 November 2010
A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
Marty Hinz, Alvin Stein, Thomas Uncini
Neuropsychiatric Disease and Treatment 2010, 6:741-747
Published Date: 9 November 2010
Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
Jason T Lerner, Noriko Salamon, Raman Sankar
Neuropsychiatric Disease and Treatment 2010, 6:731-740
Published Date: 8 November 2010
Update on treatment of partial onset epilepsy: role of eslicarbazepine
Markus Rauchenzauner, Gerhard Luef
Neuropsychiatric Disease and Treatment 2010, 6:723-730
Published Date: 2 November 2010
Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine
Michele Fornaro
Neuropsychiatric Disease and Treatment 2010, 6:719-722
Published Date: 29 October 2010
Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
Adel Gabriel
Neuropsychiatric Disease and Treatment 2010, 6:711-717
Published Date: 29 October 2010
Could lysine supplementation prevent Alzheimer’s dementia? A novel hypothesis
Robert N Rubey
Neuropsychiatric Disease and Treatment 2010, 6:707-710
Published Date: 27 October 2010
Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities
Miho Takenoshita, Tomoko Sato, Yuichi Kato, et al
Neuropsychiatric Disease and Treatment 2010, 6:699-705
Published Date: 13 October 2010
Neuroendocrine aspects of pediatric aggression: Can hormone measures be clinically useful?
Drew H Barzman, Avni Patel, Loretta Sonnier, et al
Neuropsychiatric Disease and Treatment 2010, 6:691-697
Published Date: 11 October 2010
Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia
Eric R Braverman, Amanda Lih-Chuan Chen, Thomas JH Chen, et al
Neuropsychiatric Disease and Treatment 2010, 6:681-690
Published Date: 15 October 2010
Role of paliperidone extended-release in treatment of schizoaffective disorder
Carla M Canuso, Ibrahim Turkoz, Dong Jing Fu, et al
Neuropsychiatric Disease and Treatment 2010, 6:667-679
Published Date: 28 September 2010
Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
Samuel Frank
Neuropsychiatric Disease and Treatment 2010, 6:657-665
Published Date: 28 September 2010
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
Mike Briley, Chantal Moret
Neuropsychiatric Disease and Treatment 2010, 6:647-655
Published Date: 23 September 2010
Treating Lennox–Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide
Jessica Gresham, Lea S Eiland, Allison M Chung
Neuropsychiatric Disease and Treatment 2010, 6:639-645
Published Date: 22 September 2010
Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension
Amresh Shrivastava, Megan E Johnston, Nilesh Shah, et al
Neuropsychiatric Disease and Treatment 2010, 6:633-638
Published Date: 22 September 2010
Insight in bipolar disorder: relationship to episode subtypes and symptom dimensions
Frederick Cassidy
Neuropsychiatric Disease and Treatment 2010, 6:627-631
Published Date: 21 September 2010
Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
Julie A Murphy, Jacklyn A Harris, Andrew J Crannage
Neuropsychiatric Disease and Treatment 2010, 6:619-625
Published Date: 22 September 2010
Assessing suicidal risk with antiepileptic drugs
Marco Mula, Gail S Bell, Josemir W Sander
Neuropsychiatric Disease and Treatment 2010, 6:613-618
Published Date: 14 September 2010
Brain amyloid β protein and memory disruption in Alzheimer’s disease
Weiming Xia
Neuropsychiatric Disease and Treatment 2010, 6:605-612
Published Date: 7 September 2010
Not all partial dopamine D2 receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse
Athan Spiros, Robert Carr, Hugo Geerts
Neuropsychiatric Disease and Treatment 2010, 6:589-603
Published Date: 6 September 2010
Brief assessment of negative dysmorphic signs
Patrizia Fiori, Antonio Monaco, Maria Giannetti Luigi
Neuropsychiatric Disease and Treatment 2010, 6:583-587
Published Date: 6 September 2010
Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
Rosaria Di Lorenzo, Alice Brogli
Neuropsychiatric Disease and Treatment 2010, 6:573-581
Published Date: 1 September 2010
Once-monthly paliperidone injection for the treatment of schizophrenia
Delia Bishara
Neuropsychiatric Disease and Treatment 2010, 6:561-572
Published Date: 1 September 2010
Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD)
Evangelia Stergiakouli, Anita Thapar
Neuropsychiatric Disease and Treatment 2010, 6:551-560
Published Date: 24 August 2010
Management of depression in elderly stroke patients
Johan Lökk, Ahmad Delbari
Neuropsychiatric Disease and Treatment 2010, 6:539-549
Published Date: 26 August 2010
Polyclonal light chains in cerebrovascular disease
Patrizia Fiori, Maria Giannetti Luigi, Linda Iurato, et al
Neuropsychiatric Disease and Treatment 2010, 6:533-537
Published Date: 24 August 2010
Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters
Seth D Norrholm, Tanja Jovanovic
Neuropsychiatric Disease and Treatment 2010, 6:517-532
Published Date: 24 August 2010
Distinguishing between attention-deficit hyperactivity and fetal alcohol spectrum disorders in children: clinical guidelines
Elizabeth Peadon, Elizabeth J Elliott
Neuropsychiatric Disease and Treatment 2010, 6:509-515
Published Date: 12 August 2010
Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
Laura Gedge, Lauren Lazowski, David Murray, et al
Neuropsychiatric Disease and Treatment 2010, 6:501-508
Published Date: 10 August 2010
Current and emerging treatment options in the management of Friedreich ataxia
Michelangelo Mancuso, Daniele Orsucci, Anna Choub, et al
Neuropsychiatric Disease and Treatment 2010, 6:491-499
Published Date: 30 July 2010
Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo®)
Paolo Solla, Antonino Cannas, Francesco Marrosu, et al
Neuropsychiatric Disease and Treatment 2010, 6:483-490
Published Date: 4 August 2010
Depressive and adjustment disorders – some questions about the differential diagnosis: case studies
A Presicci, P Lecce, P Ventura, et al
Neuropsychiatric Disease and Treatment 2010, 6:473-481
Published Date: 28 July 2010
Lacosamide for the prevention of partial onset seizures in epileptic adults
Anna Kelemen, Péter Halász
Neuropsychiatric Disease and Treatment 2010, 6:465-471
Published Date: 28 July 2010
Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
Wissam El-Hage, Simon A Surguladze
Neuropsychiatric Disease and Treatment 2010, 6:455-464
Published Date: 28 July 2010
Short cognitive behavioral therapy and cognitive training for adults with ADHD – a randomized controlled pilot study
Maarit Virta, Anita Salakari, Mervi Antila, et al
Neuropsychiatric Disease and Treatment 2010, 6:443-453
Published Date: 16 July 2010
Emerging role of sertindole in the management of schizophrenia
Stephanie L Cincotta, Joshua S Rodefer
Neuropsychiatric Disease and Treatment 2010, 6:429-441
Published Date: 8 July 2010
Armodafinil in the treatment of sleep/wake disorders
Jonathan RL Schwartz, Thomas Roth, Chris Drake
Neuropsychiatric Disease and Treatment 2010, 6:417-427
Published Date: 16 July 2010
Reasons for reoperation after epilepsy surgery: a review based on a complex clinical case with three operations
José F Téllez-Zenteno, Farzad Moien-Afshari, Lizbeth Hernández-Ronquillo, et al
Neuropsychiatric Disease and Treatment 2010, 6:409-415
Published Date: 7 July 2010
Overview of essential tremor
Theresa A Zesiewicz, Abinaya Chari, Israt Jahan, et al
Neuropsychiatric Disease and Treatment 2010, 6:401-408
Published Date: 7 July 2010
Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, et al
Neuropsychiatric Disease and Treatment 2010, 6:393-400
Published Date: 24 June 2010
The dual-gate lumen model of renal monoamine transport
Marty Hinz, Alvin Stein, Thomas Uncini
Neuropsychiatric Disease and Treatment 2010, 6:387-392
Published Date: 5 July 2010
Faster return to work after psychiatric consultation for sicklisted employees with common mental disorders compared to care as usual. A randomized clinical trial
Christina M van der Feltz-Cornelis, Rob Hoedeman, Fransina J de Jong, et al
Neuropsychiatric Disease and Treatment 2010, 6:375-385
Published Date: 5 July 2010
Disease-modifying therapies in relapsing–remitting multiple sclerosis
Fabricio González-Andrade, José Luis Alcaraz-Alvarez
Neuropsychiatric Disease and Treatment 2010, 6:365-373
Published Date: 6 July 2010
Getting the balance right: Established and emerging therapies for major depressive disorders
Bojana Perovic, Marija Jovanovic, Branislava Miljkovic, et al
Neuropsychiatric Disease and Treatment 2010, 6:343-364
Published Date: 5 July 2010
Leiter-R versus developmental quotient for estimating cognitive function in preschoolers with pervasive developmental disorders
Claudia Portoghese, Maura Buttiglione, Andrea De Giacomo, et al
Neuropsychiatric Disease and Treatment 2010, 6:337-342
Published Date: 28 June 2010
The role of glatiramer acetate in the early treatment of multiple sclerosis
David W Brandes
Neuropsychiatric Disease and Treatment 2010, 6:329-336
Published Date: 9 June 2010
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
Michael Pennick
Neuropsychiatric Disease and Treatment 2010, 6:317-327
Published Date: 4 June 2010
Levetiracetam as an alternative therapy for Tourette syndrome
MA Martínez-Granero, A García-Pérez, F Montañes
Neuropsychiatric Disease and Treatment 2010, 6:309-316
Published Date: 26 May 2010
Management of refractory complex partial seizures: current state of the art
David M Treiman
Neuropsychiatric Disease and Treatment 2010, 6:297-308
Published Date: 26 May 2010
Abnormal auditory forward masking pattern in the brainstem response of individuals with Asperger syndrome
Johan Källstrand, Olle Olsson, Sara Fristedt Nehlstedt, et al
Neuropsychiatric Disease and Treatment 2010, 6:289-296
Published Date: 31 May 2010
Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study
Takahiko Nagamine
Neuropsychiatric Disease and Treatment 2010, 6:281-288
Published Date: 9 June 2010
New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
Diana Domnitei, Vishal Madaan
Neuropsychiatric Disease and Treatment 2010, 6:273-279
Published Date: 17 May 2010
Structured relaxation in the treatment of akathisia: case series
Lars K Hansen, Thomas L’Allemand, Francine Thiry, et al
Neuropsychiatric Disease and Treatment 2010, 6:269-271
Published Date: 25 May 2010
Long-acting injectable antipsychotics: focus on olanzapine pamoate
JP Lindenmayer
Neuropsychiatric Disease and Treatment 2010, 6:261-267
Published Date: 27 May 2010
Trazodone effects on [3H]-paroxetine and α2-adrenoreceptors in platelets of patients with major depression
Donatella Marazziti, Giorgio Consoli, Francesca Golia, et al
Neuropsychiatric Disease and Treatment 2010, 6:255-259
Published Date: 10 May 2010
Optimal management of Alzheimer’s disease patients: Clinical guidelines and family advice
Julia Haberstroh, Harald Hampel, Johannes Pantel
Neuropsychiatric Disease and Treatment 2010, 6:243-253
Published Date: 10 May 2010
Current trends in drug treatment of obsessive–compulsive disorder
Eric H Decloedt, Dan J Stein
Neuropsychiatric Disease and Treatment 2010, 6:233-242
Published Date: 10 May 2010
Recurrent schizophrenia-like psychosis as first manifestation of epilepsy: a diagnostic challenge in neuropsychiatry
Willem MA Verhoeven, Jos IM Egger, W Boudewijn Gunning, et al
Neuropsychiatric Disease and Treatment 2010, 6:227-231
Published Date: 3 May 2010
Neuro-Behçet’s disease: A report of sixteen patients
Radi Shahien, Abdalla Bowirrat
Neuropsychiatric Disease and Treatment 2010, 6:219-225
Published Date: 4 May 2010
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management
Michele Fornaro, Matteo Martino
Neuropsychiatric Disease and Treatment 2010, 6:209-218
Published Date: 1 June 2010
Role and rationale for the use of milnacipran in the management of fibromyalgia
Jay D Kranzler, R Michael Gendreau
Neuropsychiatric Disease and Treatment 2010, 6:197-208
Published Date: 30 April 2010
Cobalamin deficiency, hyperhomocysteinemia, and dementia
Steven F Werder
Neuropsychiatric Disease and Treatment 2010, 6:159-195
Published Date: 27 April 2010
Gabapentin enacarbil – clinical efficacy in restless legs syndrome
Pinky Agarwal, Alida Griffith, Henry R Costantino, et al
Neuropsychiatric Disease and Treatment 2010, 6:151-158
Published Date: 22 April 2010
Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients
Barbara Błaszczyk, Stanisław J Czuczwar
Neuropsychiatric Disease and Treatment 2010, 6:145-150
Published Date: 20 April 2010
Hypothyroidism during neonatal and perinatal period induced by thyroidectomy of the mother causes depressive-like behavior in prepubertal rats
Marisol Pineda-Reynoso, Edgar Cano-Europa, Vanessa Blas-Valdivia, et al
Neuropsychiatric Disease and Treatment 2010, 6:137-143
Published Date: 19 April 2010
The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes
Jeff C Huffman, Christopher M Celano, James L Januzzi
Neuropsychiatric Disease and Treatment 2010, 6:123-136
Published Date: 5 May 2010
Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis
E Ece Boylu, R Erdem Togrol, Mehmet Güney Şenol, et al
Neuropsychiatric Disease and Treatment 2010, 6:119-122
Published Date: 7 April 2010
Clinical management of behavioral characteristics of Prader–Willi syndrome
Alan Y Ho, Anastasia Dimitropoulos
Neuropsychiatric Disease and Treatment 2010, 6:107-118
Published Date: 13 April 2010
Emotion recognition from stimuli in different sensory modalities in post-encephalitic patients
Yayoi Hayakawa, Masaru Mimura, Hidetomo Murakami, et al
Neuropsychiatric Disease and Treatment 2010, 6:99-105
Published Date: 29 March 2010
Daytime sleepiness in elderly Parkinson’s disease patients and treatment with the psychostimulant modafinil: A preliminary study
Johan Lökk
Neuropsychiatric Disease and Treatment 2010, 6:93-97
Published Date: 31 March 2010
Psychiatric comorbidity and suicide risk in patients with chronic migraine
Maurizio Pompili, Gianluca Serafini, Daniela Di Cosimo, et al
Neuropsychiatric Disease and Treatment 2010, 6:81-91
Published Date: 1 April 2010
Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study
Jean-Pierre Olié, David Gourion, Agnès Montagne, et al
Neuropsychiatric Disease and Treatment 2010, 6:71-79
Published Date: 23 March 2010
Adolescent mental health: Challenges with maternal noncompliance
Vicki A Nejtek, Sarah Hardy, Scott Winter
Neuropsychiatric Disease and Treatment 2010, 6:67-69
Published Date: 30 March 2010
Post-traumatic stress in patients with injury-related chronic pain participating in a multimodal pain rehabilitation program
Britt-Marie Stålnacke, Anna Östman
Neuropsychiatric Disease and Treatment 2010, 6:59-66
Published Date: 9 March 2010
Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
Izchak Kohen, Paula E Lester, Sum Lam
Neuropsychiatric Disease and Treatment 2010, 6:47-58
Published Date: 2 March 2010
Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
Jean-Michel Azorin, Charles L Bowden, Ricardo P Garay, et al
Neuropsychiatric Disease and Treatment 2010, 6:37-46
Published Date: 3 March 2010
Role of extended release quetiapine in the management of bipolar disorders
Rayan K Al Jurdi, Lena A Dixit, Martha Sajatovic
Neuropsychiatric Disease and Treatment 2010, 6:29-35
Published Date: 15 February 2010
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
Steffen Naegel, Mark Obermann
Neuropsychiatric Disease and Treatment 2010, 6:17-28
Published Date: 22 December 2009
Impulsivity, gender, and the platelet serotonin transporter in healthy subjects
Donatella Marazziti, Stefano Baroni, Irene Masala, et al
Neuropsychiatric Disease and Treatment 2010, 6:9-15
Published Date: 18 December 2009
Measuring cortisol and DHEA in fingernails: A pilot study
Fay Warnock, Kevin McElwee, Rubo J Seo, et al
Neuropsychiatric Disease and Treatment 2010, 6:1-7
Published Date: 16 December 2009